Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Ivan Perdomo"'
Autor:
Denisse Castro, Jorge J. Castillo, Ivan Perdomo, Efreen Montaño Figueroa, Cristobal Augusto Frutos Ortiz, Humberto Martínez Cordero, Mercedes Royg Arriola, Brady E Beltran, Alana Von Glasenapp, Gladys P. Agreda-Vásquez, Eduardo M. Sotomayor, Marcos Distefano, Guillermo J. Ruiz-Argüelles, Camila Peña, Katerine Garcia, Lidiane Andino, Lorena Fiad, Maria Elvira Enciso, Cristaldo Nancy, Carolina Feres, Maria Virginia Prates, Rosio Baena, Henry Idrobo, Sally Rose Paredes, Virginia Otero, Fabiola Valvert, Daniela Zambrano, Luis Villela Villela, Maria Elena Cabrera, Luis E Malpica Castillo, Alfredo Reinaldo Quiroz, Melani Otañez, Juan Ospina Idarraga, Myrna Candelaria, Juan Antonio Choque, Maria Alejandra Torres Viera, Magali DelosRios, Mariana Kalmus, Fernando Perez-Jacobo, Guilherme Fleury Perini, Ana Florencia Ramirez-Ibarguen, Julian Cordova, David Gómez-Almaguer, María Lorena Cardozo, Eloisa Riva
Publikováno v:
Blood. 136:25-27
Introduction. There are different scoring systems to differentiate risk groups in patients with DLBCL treated with chemoimmunotherapy. Those systems have used the same 5 variables (age, performance status, LDH, stage, extranodal involvement) for 27 y
Autor:
Lina Abenoza, Claudia Sossa, Humberto Martinez-Cordero, Virginia Abello-Polo, Henry Idrobo, Kenny Galvez, Juan-Manuel Herrera, Ivan Perdomo, Daniel Espinosa, Álvaro Gómez, Viviana Paredes, Rigoberto Gomez, Jose-Domingo Saavedra, Roberto Jaramillo, Mónica Osuna, Jair Figueroa, Isabel Munevar, Claudia Patricia Casas, Carmen Rosales, Carlos-Daniel Bermudez, Lina Gaviria, Álvaro Guerrero, Guillermo Quintero, Jheremy Reyez, Paola Guerrero, Luis Antonio Salazar, William Mantilla, Yazmin Borjas, Maria-Helena Solano
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S444-S445
Context The most frequently used induction treatments for newly diagnosed multiple myeloma in Colombia are VTD and CyBorD for transplant-eligible patients. Objective At present, there are no clinical studies in our region that compare the effectivene
Autor:
Efreen Montaño Figueroa, Eduardo M. Sotomayor, Victoria Otero, Juan Antonio Choque, Claudia Gajardo, Christine Rojas, Cristaldo Nancy, Luis Villela Villela, Camila Peña, Rosio Baena, Mariana Kalmus, Sofia Sanchez, Guilherme Fleury Perini, Sally Rose Paredes, Juan Felipe Lasso, Denisse Castro, Virginia Abello, Luis Malpica Castillo, Juan Ospina Idarraga, Larissa Lc Teixeira, Fernando Pérez-Jacobo, Melani Otañez, Brady E Beltran, Alana Von Glasenapp, Carolina Feres, Maria Alejandra Torres Viera, Marcos Di Stefano, Ivan Perdomo, Daniela Zambrano, Macarena Alejandra Roa Salinas, Ana Florencia Ramirez-Ibarguen, Ximena Valladares, Andrea Noboa, Lorena Fiad, Henry Idrobo, Fabiola Valvert, Jorge J. Castillo, Myrna Candelaria, Humberto Martínez Cordero, Maria Virginia Prates
Publikováno v:
Blood
Introduction: SARS-COV-2 pandemic has infected approximately 20 million people worldwide and more than 700.000 fatalities have been reported. Patients with malignant hematological diseases are at particular risk for unfavorable outcomes, including in
Autor:
Eduardo M. Sotomayor, Andrés Gómez-De León, María Alejandra Torres, Henry Idrobo, Carlos Best, Pilar León, Ana Florencia Ramirez-Ibarguen, Sally Rose Paredes, José Ascención Hernández-Hernández, Virginia Abello, Luis Malpica, Maria Elena Cabrera, David Gómez-Almaguer, Christine Rojas, Luis Villela, Victoria Otero, Lorena Fiad, Guillermo J. Ruiz-Argüelles, Efren Montaño-Figueroa, Brady E Beltran, Denisse Castro, Camila Peña, Jorge J. Castillo, Fernando Pérez-Jacobo, Myrna Candelaria, Ivan Perdomo
Publikováno v:
Clinical lymphoma, myelomaleukemia. 20(10)
We aimed at investigating the prognostic role of the neutrophil-to-lymphocyte ratio (NLR) in 2 independent cohorts of Latin American patients with diffuse large B-cell lymphoma (DLBCL) treated with chemoimmunotherapy.The learning cohort was composed
Autor:
Luis Malpica Castillo, Virginia Abello, Melani Otañez, Cristaldo Nancy, Sofia Sanchez, Larissa Lc Teixeira, Christine Rojas, Carolina Feres, Mariana Kalmus, Alan P Skarbnik, Jorge J. Castillo, Luis Villela, Maria Virginia Prates, Ivan Perdomo, Claudia Gajardo, Marcos Di Stefano, Humberto Martinez, Ana Florencia Ramirez-Ibarguen, Rosio Baena, Leonardo Javier Arcuri, Daniela Zambrano, Myrna Candelaria, Marialejandra Torres Viera, Efreen Montaño Figueroa, Juan Felipe Lasso, Juan Alejandro Ospina, Eduardo M. Sotomayor, Denisse Castro, Camila Peña, Sally Rose Paredes, Brady E Beltran, Alana Von Glasenapp, Guilherme Fleury Perini, Macarena Alejandra Roa Salinas, Ximena Valladares, Fernando Perez-Jacobo, Andrea Noboa, Victoria Otero, Juan Antonio Choque, Henry Idrobo, Fabiola Valvert, Lorena Fiad
Publikováno v:
Blood
Updated analysis confirms sustained poor prognosis of COVID-19 in patients with lymphoma in Latin America: A cohort of 160 patients from GELL. Introduction: Ongoing SARS-COV-2 pandemic has impacted the management of cancer patients worldwide. Several
Autor:
Humberto Martinez-Cordero, Virginia Abello-Polo, Claudia Casas, Maria-Helena Solano, Daniel Espinosa, Ivan Perdomo, Jheremy Reyez, Monica Osuna, Viviana Paredes, Jair Figueroa, Rigoberto Gomez, Roberto Jaramillo, Alvaro Gomez, Jose-Domingo Saavedra, Kenny Galvez, Guillermo Quintero, Lina Abenoza, Lina Gaviria, Yazmin Borjas, Henry Idrobo, William Mantilla, Claudia Sossa, Luis Salazar, Juan-Manuel Herrera, Paola Guerrero, Alvaro Guerrero, Carmen Rosales, Isabel Munevar, Carlos-Daniel Bermudez
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S256
Autor:
Laura Silva Idárraga, Luis Malpica Castillo, Humberto Martínez Cordero, Brady E Beltran, Melani Otañez, Claudia Gajardo, Fernando Pérez-Jacobo, Camila Peña, Alana Von Glasenapp, Catalina Díaz, Juan Ospina Idarraga, Denisse Castro, Guilherme Fleury Perini, Eduardo M. Sotomayor, Ana Florencia Ramirez-Ibarguen, Efreen Montaño Figueroa, Luis Villela Villela, Macarena Alejandra Roa Salinas, Sally Rose Paredes, Maria Elena Cabrera, Marcos Di Stefano, Virginia Abello, Victoria Otero, Rosio Baena, Juan Antonio Choque, Cristaldo Nancy, Maria Virginia Prates, Ivan Perdomo, Jorge J. Castillo, Lorena Fiad, Henry Idrobo, Fabiola Valvert, Myrna Candelaria, Maria Alejandra Torres Viera
Publikováno v:
Blood. 136:12-13
Introduction: Follicular lymphoma (FL) is the most common indolent non-Hodgkin lymphoma subtype seen in Western countries. However, data on FL from Latin America (LATAM) are scarce. We aimed at better understanding the clinical features, treatment pa
Autor:
Eduardo M. Sotomayor, Marialejandra Torres Viera, Luis Villela M, Victoria Otero, Mimsy Quinones, Pilar León, Jorge J. Castillo, Brady E Beltran, Camila Peña, Lorena Fiad, Yesenia M. Huerta Collado, Henry Idrobo, Ivan Perdomo, Christine Rojas, Luis E Malpica Castillo, Sally Rose Paredes, Juan Carlos Ramos, Virginia Abello, Denisse Castro
Publikováno v:
Blood. 134:4045-4045
Background : Adult T-cell leukemia/lymphoma (ATLL) is an aggressive, peripheral T-cell neoplasm associated with the human T-cell leukemia virus type 1 (HTLV-1). HTLV-1 infects up to 10 million people worldwide and is most endemic in Southwestern Japa
Autor:
Pilar León, Karen Lalupu, Ivan Perdomo, Guillermo J. Ruiz-Argüelles, Eduardo M. Sotomayor, Andrés Gómez-De León, Jorge J. Castillo, Lorena Fiad, José Ascención Hernández-Hernández, Victoria Otero, Fernando Pérez-Jacobo, Ana Florencia Ramirez-Ibarguen, Carlos Best, Marialejandra Torres Viera, Henry Idrobo, Camila Peña, Luis E Malpica Castillo, Myrna Candelaria, Denisse Castro, Sally Rose Paredes, Brady E Beltran, Melani Otañez, Christine Rojas, Efreen Montaño Figueroa, David Gómez-Almaguer, Luis Villela M
Publikováno v:
Blood. 134:4121-4121
Introduction: Diffuse Large B-Cell Lymphoma (DLBCL) is the most frequent subtype of high-grade lymphoma in Latin American patients. The neutrophil-to-lymphocyte ratio (NLR) has shown to be prognostic in patients with DLBCL in Asia, Europe, and the Un
Autor:
Ivan Perdomo, Humberto Martínez Cordero, Leonardo Enciso-Olivera, Paola Spirko, Cristina Acon-Solano, Amado Karduss, Diana Otero-de la Hoz, Guillermo León-Basantes, Paola Omaña, Julio Solano-Vega, Álvaro Guerrero, Claudia Marcela Chalela, Daniel Espinosa, Alejandro Ruiz-Patiño, Natalia Villarroya, Paola Guerrero, Carmen Rosales, Juan Manuel Herrera, Mario Pereira, Jose Sandoval-Sus, Mónica Arévalo-Zambrano, Claudia Sossa, Mónica Osuna, Ulrike Heider, Virginia Abello, Víctor Rodriguez-Sanjuan, Angela María Peña, Bonell Patiño
Publikováno v:
Blood. 134:5275-5275
Introduction: High-dose chemotherapy followed by autologous stem-cell transplantation (auto-HCT) is standard of care for patients with relapsed or primary refractory classical Hodgkin lymphoma (cHL). Brentuximab vedotin (BV) consolidation after auto-